Abstract：
:We evaluated ancestry effects on mutation rates, DNA methylation, and mRNA and miRNA expression among 10,678 patients across 33 cancer types from The Cancer Genome Atlas. We demonstrated that cancer subtypes and ancestry-related technical artifacts are important confounders that have been insufficiently accounted for. Once accounted for, ancestry-associated differences spanned all molecular features and hundreds of genes. Biologically significant differences were usually tissue specific but not specific to cancer. However, admixture and pathway analyses suggested some of these differences are causally related to cancer. Specific findings included increased FBXW7 mutations in patients of African origin, decreased VHL and PBRM1 mutations in renal cancer patients of African origin, and decreased immune activity in bladder cancer patients of East Asian origin.
journal_name
Cancer Celljournal_title
Cancer cellauthors
Carrot-Zhang J,Chambwe N,Damrauer JS,Knijnenburg TA,Robertson AG,Yau C,Zhou W,Berger AC,Huang KL,Newberg JY,Mashl RJ,Romanel A,Sayaman RW,Demichelis F,Felau I,Frampton GM,Han S,Hoadley KA,Kemal A,Laird PW,Lazar AJdoi
10.1016/j.ccell.2020.04.012subject
Has Abstractpub_date
2020-05-11 00:00:00pages
639-654.e6issue
5eissn
1535-6108issn
1878-3686pii
S1535-6108(20)30211-7journal_volume
37pub_type
杂志文章相关文献
CANCER CELL文献大全abstract：:In this issue of Cancer Cell, Sturm et al. report that global DNA methylation patterns in glioblastoma multiforme divide adult and pediatric tumors into subgroups that have characteristic DNA mutations, mRNA profiles, and most importantly, different clinical behaviors. These findings suggest novel opportunities for th...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2012.10.001
更新日期：2012-10-16 00:00:00
abstract：:To identify regulatory drivers of prostate cancer malignancy, we have assembled genome-wide regulatory networks (interactomes) for human and mouse prostate cancer from expression profiles of human tumors and of genetically engineered mouse models, respectively. Cross-species computational analysis of these interactome...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2014.03.017
更新日期：2014-05-12 00:00:00
abstract：:The telomere-stabilizing enzyme telomerase is induced in tumors and functionally associated with unlimited replicative potential. To further explore its necessity, transgenic mice expressing SV40 or HPV16 oncogenes, which elicit carcinomas in pancreas and skin, respectively, were rendered telomerase-deficient. Absence...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2004.08.032
更新日期：2004-10-01 00:00:00
abstract：:The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) a...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(02)00102-2
更新日期：2002-08-01 00:00:00
abstract：:In this study, we show that the formation of polyploidy following sustained mitotic checkpoint activation appears to be preceded by the ubiquitin-dependent proteolysis of hBubR1. In addition, the level of hBubR1 is significantly reduced not only in polyploid cells created by sustained mitotic spindle damage, but also ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(03)00302-7
更新日期：2003-12-01 00:00:00
abstract：:Gankyrin is an ankyrin repeat oncoprotein commonly overexpressed in hepatocellular carcinomas. Gankyrin interacts with the S6 proteasomal ATPase and accelerates the degradation of the tumor suppressor Rb. We show here that gankyrin has an antiapoptotic activity in cells exposed to DNA damaging agents. Downregulation o...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.06.006
更新日期：2005-07-01 00:00:00
abstract：:Breast cancer is a heterogeneous disease and can be classified based on gene expression profiles that reflect distinct epithelial subtypes. We identify prostate-derived ETS factor (PDEF) as a mediator of mammary luminal epithelial lineage-specific gene expression and as a factor required for tumorigenesis in a subset ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2013.04.026
更新日期：2013-06-10 00:00:00
abstract：:Therapeutic resistance is a major challenge in cancer treatment. In this issue of Cancer Cell, Kurppa et al. demonstrated that a senescence-like state enables lung cancer cells to survive dual inhibition of EGFR and MEK. This was mediated by the YAP/TEAD pathway, which drives epigenomic reprogramming and EMT to counte...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2019.12.008
更新日期：2020-01-13 00:00:00
abstract：:Whether metastasis-specific genetic alterations exist remains controversial. The study by Yates et al. in this issue of Cancer Cell provides evidence that metastases emerge late during primary breast cancer progression and that additional driver mutations are often acquired, posing both challenges and opportunities fo...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2017.07.011
更新日期：2017-08-14 00:00:00
abstract：:Aneuploidy is a hallmark of cancer, although its effects on tumorigenesis are unclear. Here, we investigated the relationship between aneuploidy and cancer development using cells engineered to harbor single extra chromosomes. We found that nearly all trisomic cell lines grew poorly in vitro and as xenografts, relativ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2016.12.004
更新日期：2017-02-13 00:00:00
abstract：:The involvement of the homologous to E6-AP carboxyl terminus (HECT)-type E3s in crucial signaling pathways implicated in tumorigenesis is presently an area of intense research and extensive scientific interest. This review highlights recent discoveries on the ubiquitin-mediated degradation of crucial tumor suppressor ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/j.ccr.2008.06.001
更新日期：2008-07-08 00:00:00
abstract：:Adenosine deaminase associated with RNA1 (ADAR1) deregulation contributes to therapeutic resistance in many malignancies. Here we show that ADAR1-induced hyper-editing in normal human hematopoietic progenitors impairs miR-26a maturation, which represses CDKN1A expression indirectly via EZH2, thereby accelerating cell-...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2018.11.017
更新日期：2019-01-14 00:00:00
abstract：:Amino acid (AA) is a potent mitogen that controls growth and metabolism. Here we describe the identification of Rab1 as a conserved regulator of AA signaling to mTORC1. AA stimulates Rab1A GTP binding and interaction with mTORC1 and Rheb-mTORC1 interaction in the Golgi. Rab1A overexpression promotes mTORC1 signaling a...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2014.09.008
更新日期：2014-11-10 00:00:00
abstract：:Agonistic antibodies specific for members of the tumor necrosis factor receptor protein family hold great promise for immunotherapy of cancer. In this issue of Cancer Cell, White and colleagues provide evidence that the human IgG2 subclass may represent a superior backbone for the use of these antibodies in human ther...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2014.12.010
更新日期：2015-01-12 00:00:00
abstract：:Transcription factor NF-kappaB has been implicated in cancer development due to its ability to upregulate expression of genes with potentially prooncogenic functions, such as cell cycle regulators and antiapoptotic proteins (Karin et al., 2002). A recent report by suggests that a structural motif, a death domain (DD),...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(02)00213-1
更新日期：2002-12-01 00:00:00
abstract：:The transcription factor Meis1 drives myeloid leukemogenesis in the context of Hox gene overexpression but is currently considered undruggable. We therefore investigated whether myeloid progenitor cells transformed by Hoxa9 and Meis1 become addicted to targetable signaling pathways. A comprehensive (phospho)proteomic ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2017.03.001
更新日期：2017-04-10 00:00:00
abstract：:Human T cell leukemias can arise from oncogenes activated by specific chromosomal translocations involving the T cell receptor genes. Here we show that five different T cell oncogenes (HOX11, TAL1, LYL1, LMO1, and LMO2) are often aberrantly expressed in the absence of chromosomal abnormalities. Using oligonucleotide m...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/s1535-6108(02)00018-1
更新日期：2002-02-01 00:00:00
abstract：:Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human malignancies. To investigate the cellular origin(s) of this cancer, we determined the effect of PDAC-relevant gene mutations in distinct cell types of the adult pancreas. We show that a subpopulation of Pdx1-expressing cells is susceptible to onco...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2009.09.027
更新日期：2009-11-06 00:00:00
abstract：:In a recent study, Leucci et al. report a role for the long non-coding RNA SAMMSON in driving mitochondrial function in melanoma. Targeting SAMMSON, the gene of which is frequently co-amplified with MITF, highlights a new cell-type-specific therapeutic vulnerability in melanoma irrespective of BRAF, NRAS, or p53 statu...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2016.04.010
更新日期：2016-05-09 00:00:00
abstract：:The COVID-19 pandemic is profoundly changing cancer researchers and cancer research. Leaders from different fields and at different career stages share their perspectives. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.10.007
更新日期：2020-11-09 00:00:00
abstract：:To investigate the role of signaling by the small GTPase Ral, we have generated mice deficient for RalGDS, a guanine nucleotide exchange factor that activates Ral. We show that RalGDS is dispensable for mouse development but plays a substantial role in Ras-induced oncogenesis. Lack of RalGDS results in reduced tumor i...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2005.01.029
更新日期：2005-03-01 00:00:00
abstract：:The hedgehog (Hh) signaling pathway plays many roles in invertebrate and vertebrate development. For example, specific inhibition of sonic Hh expression is critical during early stages of pancreas organogenesis, but an active Hh pathway appears to be required for maintenance of adult endocrine functions. Mutational in...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(03)00246-0
更新日期：2003-10-01 00:00:00
abstract：:Targeted protein degradation is an emerging technology for drug development. An article published in Nature reported a novel mechanism of targeted protein degradation triggered by small-molecule-induced polymerization of the oncogenic transcription factor BCL6. ...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2020.12.020
更新日期：2021-01-11 00:00:00
abstract：:In this issue of Cancer Cell, Nagaraja et al. dissect the molecular mechanisms underlying therapeutic responses to transcriptional disruptors in the fatal pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG). Moreover, they identify super-enhancers mediating these effects, highlighting how normal brain devel...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccell.2017.04.008
更新日期：2017-05-08 00:00:00
abstract：:Activating mutations in GNAQ/GNA11, encoding Gαq G proteins, are initiating oncogenic events in uveal melanoma (UM). However, there are no effective therapies for UM. Using an integrated bioinformatics pipeline, we found that PTK2, encoding focal adhesion kinase (FAK), represents a candidate synthetic lethal gene with...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccell.2019.01.009
更新日期：2019-03-18 00:00:00
abstract：:Activating mutations in the FLT3 receptor tyrosine kinase occur in 30% of patients with acute myeloid leukemia. Small molecule FLT3 kinase inhibitors show selective antitumor activity in preclinical models. Clinical studies are underway. ...
journal_title：Cancer cell
pub_type： 杂志文章,评审
doi：10.1016/s1535-6108(02)00080-6
更新日期：2002-06-01 00:00:00
abstract：:Mutations in VHL, RET, NF1, SDHB, SDHC, and SDHD can give rise to pheochromocytoma/paraganglioma. These different genetic lesions may all act by decreasing the activity of a 2-oxoglutarate-dependent oxygenase, SM-20/EglN3/PHD3, resulting in reduced apoptosis of neural crest cells during development. ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2005.07.012
更新日期：2005-08-01 00:00:00
abstract：:In a recent issue of Cell, Kumar and colleagues uncovered a synthetic lethal interaction between oncogenic KRAS and the transcription factor GATA2 in non-small cell lung carcinoma. Pharmacological inhibition of GATA2-mediated pathways with bortezomib and fasudil results in dramatic tumor inhibition. These observations...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2012.04.032
更新日期：2012-05-15 00:00:00
abstract：:The Twist1 transcription factor is known to promote tumor metastasis and induce Epithelial-Mesenchymal Transition (EMT). Here, we report that Twist1 is capable of promoting the formation of invadopodia, specialized membrane protrusions for extracellular matrix degradation. Twist1 induces PDGFRα expression, which in tu...
journal_title：Cancer cell
pub_type： 杂志文章
doi：10.1016/j.ccr.2011.01.036
更新日期：2011-03-08 00:00:00
abstract：:Even in the presence of an adequate oxygen supply, many tumors metabolize the majority of the glucose they take up through glycolysis. It has been a long-held belief that this glycolytic phenotype is due to cancer-specific defects in mitochondrial oxidative phosphorylation. In this issue of Cancer Cell, Fantin et al. ...
journal_title：Cancer cell
pub_type： 评论,杂志文章
doi：10.1016/j.ccr.2006.05.012
更新日期：2006-06-01 00:00:00
